000			01991 a2200613 4500
005			20250513170456.0
264		0	_c19990527
008			199905s 0 0 eng d
022			_a0264-410X
024	7		_a10.1016/s0264-410x(98)00250-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aTsunoda, I
245	0	0	_aLipopeptide particles as the immunologically active component of CTL inducing vaccines. _h[electronic resource]
260			_bVaccine _cFeb 1999
300			_a675-85 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAmino Acid Sequence
650	0	4	_aAnimals
650	0	4	_aEpitopes, T-Lymphocyte _ximmunology
650	0	4	_aFemale
650	0	4	_aH-2 Antigens _xmetabolism
650	0	4	_aHistocompatibility Antigens Class II _xmetabolism
650	0	4	_aInfluenza Vaccines _ximmunology
650	0	4	_aLipoproteins _ximmunology
650	0	4	_aLymphocyte Activation _ximmunology
650	0	4	_aMast-Cell Sarcoma
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Inbred DBA
650	0	4	_aMolecular Sequence Data
650	0	4	_aNucleocapsid Proteins
650	0	4	_aNucleoproteins _ximmunology
650	0	4	_aOvalbumin _ximmunology
650	0	4	_aParticle Size
650	0	4	_aPeptide Fragments _ximmunology
650	0	4	_aRNA-Binding Proteins
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aTumor Cells, Cultured
650	0	4	_aViral Core Proteins _ximmunology
700	1		_aSette, A
700	1		_aFujinami, R S
700	1		_aOseroff, C
700	1		_aRuppert, J
700	1		_aDahlberg, C
700	1		_aSouthwood, S
700	1		_aArrhenius, T
700	1		_aKuang, L Q
700	1		_aKubo, R T
700	1		_aChesnut, R W
700	1		_aIshioka, G Y
773	0		_tVaccine _gvol. 17 _gno. 7-8 _gp. 675-85
856	4	0	_uhttps://doi.org/10.1016/s0264-410x(98)00250-3 _zAvailable from publisher's website
999			_c10027739 _d10027739